Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0602 CHF | -7.38% |
|
+2.03% | +30.87% |
Jun. 06 | Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024 | |
Jun. 06 | Addex Therapeutics' Q1 Net Loss Widens; Revenue Down | MT |
Business Summary
Number of employees: 23
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Small-molecule Pharmaceutical Products
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +13.99% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 53 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Vincent Lawton
CHM | Chairman | 75 | 09-04-15 |
Roger G. Mills
CTO | Chief Tech/Sci/R&D Officer | 67 | 16-11-27 |
Isaac Manke
BRD | Director/Board Member | 47 | 17-12-31 |
Ray Hill
BRD | Director/Board Member | 79 | 08-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 184,354,496 | 91,486,750 ( 49.63 %) | 86,047,246 ( 46.67 %) | 49.63 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ADDEX THERAPEUTICS LTD 23.93% | 44,113,438 | 23.93% | 3,501,284 $ |
Company contact information
Addex Therapeutics Ltd.
9, Chemin des Mines Plan-les-Ouates
1202, Geneva
+41 22 884 1555
http://www.addextherapeutics.com![address Addex Therapeutics Ltd(ADXN)](https://cdn.zonebourse.com/static/address/261774.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.87% | 6.59M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- ADXN Stock
- Company Addex Therapeutics Ltd